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Summary 
 
Objective 
To define the clinical features and outcomes of neonatal listeriosis, and identify the 
maternal risk factors to seek scope for improvement.  
 
Methods 
Neonatal listeriosis was identified prospectively from a United Kingdom neonatal infection 
surveillance network (neonIN) between 2004 and 2014. The participating neonatal units 
completed a study-specific proforma.  
 
Results 
 
The incidence of neonatal listeriosis was 3.4 per 100,000 live births. Of the 21 cases 
identified, 19 were confirmed with a median gestational age of 33 weeks and a median birth 
weight of 1960g. The majority had clinical features (95%, 18/19), presented within the first 
24 hours (95%, 18/19), and received penicillin empirically (94%, 18/19). The neonatal case-
fatality rate was 21% (24% if probable cases were included). A proportion of mothers were 
investigated (60%, 12/18) and diagnosed with listeriosis (58%, 7/12); 32% (6/19) were 
treated with antibiotics but only 33% (6/12) included penicillin.  
 
Discussion 
 
Despite its rarity and the prompt and appropriate use of antibiotics neonatal listeriosis has a 
high case-fatality rate. There is room for improvement in the adherence to the national 
guidance in the choice of empiric antibiotics for puerperal sepsis, which would target 
listeriosis. Strategies should be in place to prevent pregnancy-associated listeriosis in higher 
risk population. 
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Introduction 
 
Listeria monocytogenes is a Gram-positive bacillus. L. monocytogenes causes listeriosis, an infection 
predominantly transmitted through the consumption of contaminated food. Recent estimates 
suggest that listeriosis is the most common cause of food-related deaths in the UK (130 deaths in 
2005) [1]. The incidence of listeriosis in pregnancy is 12 per 100,000, compared with a rate of 0.7 per 
100,000 in the general population [14]. 
 
For an antibiotic to be effective against l. monocytogenes, the antibiotic must penetrate into the 
host cell, maintain a high concentration and bind to the penicillin-binding protein (PBP), which 
causes cell death. Penicillin, amoxicillin and ampicillin have been used most extensively in the 
treatment of listeriosis as these drugs block several PBPs and do penetrate intracellularly. Some in-
vitro studies also suggest a synergistic effect when gentamycin is added to the treatment regimen 
[9]. Studies in Denmark and Northern Italy found l. monocytogenes human isolates to be susceptible 
to ampicillin, amoxicillin, benzylpenicillin, meropenem, erythromycin and gentamicin [12,13]. L. 
monocytogenes is intrinsically resistant to broad-spectrum cephalosporin antibiotics, which are 
commonly used in treatment of bacterial infections [6]. 
 
Neonatal listeriosis occurs via congenital infection. In the UK, it is the third most common cause of 
early-onset neonatal infection [3] and the fourth most common cause of early-onset neonatal 
meningitis [7]. It manifests commonly in the first 24 to 72 hours of life (62% of cases) [3]. Early-onset 
neonatal listeriosis can manifest as bacteraemia, meningitis and less commonly pneumonia. Late-
onset neonatal listeriosis is most commonly associated with meningitis [2]. 
 
Neonatal listeriosis is associated with high case fatality rates. In the UK between 1967 and 1985, 248 
out of 722 cases of human listeriosis (34%) were associated with pregnancy of which 42 cases 
resulted in intrauterine deaths (19%) and 47 in neonatal deaths (35%), with an overall case fatality 
rate of 50% [4]. 
 
This study aims to define the clinical features, risk factors and outcomes of neonatal listeriosis in a 
UK neonatal infection network over a period of 11 years. 
 
 
Materials and Methods 
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Cases of neonatal listeriosis were prospectively identified between January 2004 and December 
2014 through neonIN, a neonatal infection surveillance network (www.neonin.org.uk). The 
contributing centres voluntarily collect data on culture-positive neonatal infections onto the web-
based research database, which is also crosschecked with laboratory records to ensure validity and 
quality.  
 
All neonIN centres in the UK contributing data within the study period were contacted and 
requested to complete a study-specific proforma for additional information (maternal and neonatal 
demographics, risk factors, clinical features, antimicrobial treatments and outcomes) on all cases of 
neonatal listeriosis. Cases were categorised as confirmed (defined as a case when l. monocytogenes 
was isolated from a normally sterile culture site of the neonate) and probable (defined as a case 
when l. monocytogenes was isolated from a normally sterile culture site of the mother, but no 
bacteria is isolated from a normally sterile culture site of the neonate who is clinically felt to be 
septic), and were analysed separately. 
 
The data was analysed on Microsoft Excel 2010. Comparisons were made with chi-square test for 
the data on ethnic distribution. The incidence of neonatal listeriosis was calculated using the 
cumulative hospital life births as a denominator.  
 
NeonIN received ethics approval from the London-Surrey Borders Research Ethics Committee in 
2005 (05/Q0806/34) and in 2010. Each participating centre received separate approval from their 
local ethics committees prior to joining the network. 
 
 
Results 
 
Over the 11-year period, 18 neonatal units reported 21 cases of neonatal listeriosis. The overall 
incidence was 3.4 per 100,000 live births. Of the 21 cases identified, 19 were confirmed and 2 were 
probable.  An overview of the maternal and neonatal results can be seen in Table 1 and Table 2 
respectively. 
 
 
Maternal Results 
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The median maternal age was 29 years (range 21-42, IQR 9). Of the 14 cases recorded (13 in England 
and 1 in Scotland), 50% were Caucasians, 29% Afro-Caribbeans and 21% Asians (Table 1). When 
comparing the data on ethnic distribution from the neonIN-participating centres in England against 
the Office for National Statistics population data in England, we identified a disproportionally high 
representation of Asian and Afro-Caribbean women in our sample (p <0.001) [5].  
 
Clinical features were present in 95% (20/21) of mothers antenatally with onset of preterm labour 
being the most common. Complications during labour occurred in 62% (13/21). Of the 20 cases 
recorded, 60% (12/20) had blood cultures performed of which 58% (7/12) were positive for l. 
monocytogenes. Overall, 55% (11 out of 20 recorded cases) were not diagnosed with maternal 
infection. Of the 19 cases recorded, 32% (6/19) received antibiotics pre-delivery; one-third (2/6) 
included penicillin and two-thirds (4/6) included cephalosporins (Table 1).  
 
 
Neonatal Results – Confirmed Cases 
 
Of the 19 confirmed cases of neonatal listeriosis, the median gestational age was 33 weeks (27-38 
weeks, IQR 5 weeks), the median birth weight was 1960g (1070-3210g, IQR 1002g), 90% (17/19) 
were born at less than 37 gestation weeks, 63% (12/19) had a birth weight of less than 2500g and 
21% (4/19) had a birth weight of less than 1500g (Table 2). 
 
Clinical features were present in 95% (18/19) of neonates with respiratory distress being the most 
common, and 95% (18/19) of the neonates presented within the first 24 hours. Meconium stained 
liquor was present in 62% (13/19). Cardio-respiratory support was required in 84% (16/19). In terms 
of diagnosis, 90% (17/19) were diagnosed with septicaemia, 21% (4/19) with meningitis and 5% 
(1/19) with pneumonia. The one (5%) neonate who presented after the first 24 hours did so at 10 
days of age with pyrexia and was diagnosed with meningitis (Table 2).  
 
In terms of treatment, 94% (17/18) of neonates with early-onset infection received penicillin 
empirically and 1 (6%) received a cephalosporin. Antibiotics were administered within 1 hour of birth 
in 67% (8/12), between 1 to 2 hours after birth in 17% (2/12) and more than 2 hours after birth in 
17% (2/12). The neonate with late-onset listerial meningitis also received a penicillin as part of the 
empiric treatment (Table 2). The duration of penicillin treatment was variable (Table 2); of the 3 
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neonates with meningitis, 2 completed a 21-day course and 1 a 50-day course, and of the 10 with 
septicaemia, 7 completed a 21-day and 3 a 14-day course.  
 
Looking at outcome, 21% (4/19) died in the neonatal period (all 4 within 7 days of disease onset). Of 
those that survived the neonatal period, 40% (6/15) had neurological and/or neurodevelopmental 
impairment at follow-up; 2 had developmental delay, 1 had hypertonia and a divergent squint, 1 had 
epilepsy, 1 had hydrocephalus requiring shunting and 1 had severe cerebral palsy who died at age 7 
years. 
 
 
Neonatal Results - Probable Cases 
 
There were 2 reported probable cases of neonatal listeriosis.  
 
One was born at 27 gestation weeks via emergency caesarean-section following maternal pyrexia 
and pathological fetal cardiotocography, and presented with respiratory distress, lethargy, 
bradycardia and raised inflammatory markers. The empiric treatment included a penicillin but the 
neonate died on day 6. Listeria monocytogenes was isolated from the maternal blood culture.  
 
The other was born at 30 weeks gestation via emergency caesarean-section following maternal 
pyrexia, preterm rupture of membrane and pathological fetal cardiotocography, and presented with 
a rash, respiratory distress and raised inflammatory markers. This neonate was treated with a 21-day 
course of penicillin and survived the neonatal period with no neurological impairment at follow up.  
L. monocytogenes was cultured from the maternal vaginal swab. 
 
 
Discussion 
 
The study has highlighted some important lessons for clinicians and public health specialists. 
 
The overall incidence of neonatal listeriosis in our study population was 3.4 per 100,000 live births. 
This is lower when compared to other countries; for example in the United States of America the 
incidence of neonatal listeriosis is 8.6 per 100,000 live births [15] and in Israel it is up to 25.5 per 
100,000 live births [16]. Neonatal listeriosis is also rarer when compared to the more common cause 
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of neonatal infection, such as Group B streptococcal infection, with an incidence of 72 per 100,000 
live births [17]. Therefore, neonatal listeriosis remains to be a rare disease. However, the case-
fatality rate of neonatal listeriosis remains high; in our case series this was 21% (24% if probable 
cases were included) whereas the more common Group B streptococcal infection has a lower fatality 
rate (9.7%) [17].  Therefore, despite its rarity, improvements in the recognition and prevention of 
listeriosis need to be identified. 
 
There is little scope for improvement in the choice or speed of therapy for neonates, as the vast 
majority with early-onset infection received penicillin empirically (95%, 18/19) within the first 2 
hours (83%, 10/12). This may reflect the targeted use of antibiotics to prevent early-onset group B 
streptococcal infections, which has also been suggested in a recent study to have a possible role in 
the reduction of neonatal listeriosis [11].  Of the 4 neonates who died from listerial infection, all 
received a penicillin and gentamicin empirically, of which 2/3 of those who received benzylpenicillin 
were switched onto amoxicillin within 24 hours of life following the culture of l. monocytogenes. Of 
the 6 neonates with neurological and/or neurodevelopmental impairment at follow-up, only 1 
received a cephalosporin empirically.  
 
Of the 4 mothers of the neonates who died of listerial infection, 2 (50%) did not receive antepartum 
antibiotics and 2 (50%) received cephalosporins. This might suggest that there is a worse outcome in 
neonatal listeriosis with mothers who were not treated or inadequately treated.  
 
We found that the majority (95%) of mothers presented with non-specific clinical features. This may 
be the reason why a significant proportion were not investigated and subsequently not treated as 
puerperal infection. The most common feature in mothers who were not investigated and treated 
(no culture performed on any sterile site and no antibiotics commenced) is reduce foetal movement 
(63%, 5/8), which is not a feature recognised to be associated with puerperal infection [10]. 
Therefore a lower threshold for screening of puerperal sepsis may not be the solution. However, the 
choice of empiric treatment for puerperal sepsis can be improved to follow the national guidance, 
which is designed to treat listeria along with more common bacterial causes in puerperal sepsis. The 
Royal College of Obstetricians and Gynaecologists (RCOG) has published a guideline on the 
management of sepsis in the puerperium (accredited by NICE guidelines) which includes guidance on 
empiric antimicrobials; cephalosporins were not part of the suggested regimens and a combination 
of clindamycin with either piperacillin/tazobactam or a carbapenem was recommended to provide a 
broad cover for severe sepsis [10].  
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The study suggests a disproportionally high representation of Asian and Afro-Caribbean women with 
listeriosis in England, as highlighted in the literature [5]. Studies into better understanding of the 
ethnicities and dietary characteristics may point towards those at high risk of the disease to 
implement strategies at preventing pregnancy-associated listeriosis. This will also provide further 
valuable information on how to effectively tailor communication strategies, with the help of public 
health specialists.  
 
There are limitations in this study. Although the data collection in the neonIN database is 
prospective, participants also gathered additional information retrospectively which resulted in 
some data being incomplete such as maternal ethnicity. This acknowledged, Afro-Caribbean women 
remained over-represented in our sample when compared to the national average in England. As a 
consequence of the data being derived from an on-going survey, the follow-up period of the children 
was not homogenous. In addition, this study is limited to the units participating in the neonIN 
surveillance database. However, we believe that the neonIN data are representative of the national 
neonatal listeriosis as is the case for group B streptococcus in a previous study [3]. A prospective 
national epidemiological study, such as a British Paediatric Surveillance Unit (BPSU) study could offer 
a more complete and unbiased perspective. 
Tables 
 
Table 1: Maternal Results  
 
Case  Maternal  
Age  
Ethnicity Symptom/ 
Sign(s) 
Labour 
Complications 
Mec.-
stained 
Liquor 
Initial  
WCC 
(10*9/L) 
Initial 
CRP 
(mg/L) 
Source  
of +ve 
Culture 
Diagnosis Pre-delivery 
Antibiotic(s) 
1 37 Afro-
Caribbean 
↓ fetal movements APH, 
suboptimal 
CTG 
Yes 21.5 94 Blood Septicaemia Ciprofloxacin, 
benzylpenicillin 
2 29 Afro-
Caribbean 
Preterm labour, pyrexia, 
abdo. pain  
Suboptimal 
CTG 
Yes 7.6 144 Blood Septicaemia Cefuroxime, 
metronidazole 
3 32 NR Preterm labour None No NP NP NP None None 
4 
29 NR 
Preterm labour, pyrexia, 
abdo. pain, diarrhoea, 
vag. bleed  
APH, 
suboptimal 
CTG 
No 30 NP NI Septicaemia, 
chorioamnionitis 
None 
5 29 NR Flu-like symptoms None Yes NP NP NP None None 
6 21 NR Preterm labour, ↓ fetal 
movements, preterm 
ROM 
Suboptimal 
CTG 
Yes 34.3 4 NI None None 
7 34 NR ↓ fetal movements Suboptimal 
CTG 
No NP NP NP None None 
8 24 NR Preterm labour None Yes NP NP NP None None 
9 29 NR Preterm labour, ↓ fetal 
movements 
None Yes 28.7 100.2 NP None None 
10 31 Caucasian Pyrexia, preterm ROM Suboptimal 
CTG 
Yes 20.5 23 vag. 
swab 
Chorioamnionitis Cefuroxime, 
metronidazole 
11 25 Caucasian Preterm labour None Yes NP NP NI None None 
12 26 Caucasian Pyrexia Suboptimal 
CTG 
No NR 48 Blood Septicaemia, 
chorioamnionitis 
Cefuroxime, 
metronidazole 
13 34 Caucasian ↓ fetal movements Suboptimal 
CTG 
Yes 8.1 14 NP None None 
14 37 Caucasian Preterm labour, preterm 
ROM 
None No 21.2 137 Blood Septicaemia, 
chorioamnionitis 
NR 
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15 26 Asian ↓ fetal movements None Yes 25.6 NP NP None None 
16 31 Afro-
Caribbean 
Preterm labour, preterm 
ROM, foul-smelling liquor 
None Yes 6.9 22 Placenta Chorioamnionitis Amoxicillin 
17 21 Caucasian None Suboptimal 
CTG 
Yes 16 215 NI Chorioamnionitis None 
18 42 Caucasian ↓ fetal movements Suboptimal 
CTG 
No NP NP NP None None 
19 25 Asian ↓ fetal movements Suboptimal 
CTG 
Yes 14.1 17 NI None None 
20 40 Asian Preterm labour, pyrexia, 
flu-like symptoms, vag. 
bleed 
Suboptimal 
CTG 
Yes 23.8 122 Placenta Chorioamnionitis Cephalexin, 
metronidazole 
21 27 Afro-
Caribbean 
Preterm labour, pyrexia Suboptimal 
CTG 
No 21.3 NR NR NR NR 
 
NR, not recorded; ↓, reduced; abdo., abdominal; vag., vaginal; ROM, rupture of membrane; APH, antepartum haemorrhage; CTG, cardiotocography; Em. CS, emergency caesarean 
section; SVD, spontaneous vaginal delivery; Mec, meconium; NP, not performed; NI, not isolated; WCC, white cell count; CRP, C-reactive protein; +ve, positive;
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Table 2: Neonatal Results 
 
Case  Birth Weight(g) Gestation  
(weeks) 
5 min 
Apgar 
Symptom/ 
Sign(s) 
Maximum 
Respiratory 
Support 
Inotropic 
Support 
Peak 
CRP 
(mg/L) 
Diagnosis Source of 
culture 
LP  Empiric 
Antibiotic(s) 
Antibiotics 
Onset (hours 
post birth) 
Length of 
Antibiotic(s)  
(days) 
Neurological 
Outcome at 
Follow-up 
Death 
within 
Neonatal 
Period 
1 1260 29 5 Resp. distress, rash, 
hypoglycaemia 
IV Yes 112 Septicaemia Blood NP Amoxicillin, 
gentamicin 
NR 1 (until 
death) 
NA Yes 
2 2860 38 5 Resp. distress IV+NO Yes >250 Septicaemia Blood NP Benzylpenicillin, 
gentamicin 
NR NR NA Yes 
3 1835 33 3 Resp. distress, lethargy, 
hypoglycaemia, seizure 
IV+NO Yes NR Septicaemia Blood NAD  Amoxicillin NR 21 Epilepsy No 
4 2560 35 8 Resp. distress NIV No 104 Septicaemia Blood, 
superficial 
swab 
NAD Benzylpenicillin, 
gentamicin 
2 14 NAD No 
5 2500 38 9 Resp. distress, poor feeding IV+HFOV+NO Yes NR Septicaemia Blood NAD Benzylpenicillin, 
gentamicin 
22 NR NA Yes 
6 1310 29 7 Resp. distress, lethargy, 
bradycardia, seizure 
IV Yes 87 Septicaemia, 
meningitis 
Blood NP Benzylpenicillin, 
gentamicin 
1 3 (until 
death) 
NA Yes 
7 3210 36 9 None None No 40 Septicaemia Blood Bloody tap Benzylpenicillin 28 14 NAD No 
8 1070 27 5 Resp. distress IV No 71 Septicaemia Blood Bloody tap Benzylpenicillin, 
gentamicin 
2 21 NAD No 
9 1765 32 8 Resp. distress, rash, 
bradycardia, hepatomegaly 
IV No 40 Septicaemia Blood, 
superficial 
swab 
*WCC505, 
100% 
lymphocytes, 
no growth 
Benzylpenicillin, 
amikacin 
1 21 NAD No  
#10 1535 30 8 Resp. distress, rash NIV No 42 Septicaemia NI NP Benzylpenicillin, 
gentamicin 
NR 21 NAD No 
11 2865 36 9 Pyrexia None No 13 Meningitis CSF *WCC768, 
80% 
monocytes 
Amoxicillin, 
cefotaxime 
10 days 21 NAD No 
#12 700 27 6 Resp. distress, lethargy, 
bradycardia 
IV+HFOV Yes 31 Septicaemia, 
pneumonia 
NI NP Benzylpenicillin, 
gentamicin 
<1 6 (until 
death) 
NA Yes 
13 1960 32 7 Resp. distress, lethargy, 
bradycardia 
IV No 175 Septicaemia Blood NAD Amoxicillin, 
gentamicin 
NR 14 NAD No 
14 1760 31 7 Resp. distress IV No 97 Meningitis Stool *WCC2660, 
75% 
polymorphs, 
no growth 
Amoxicillin, 
cefotaxime 
<1 50 Hydrocephalus No  
15 2150 34 6 Resp. distress None No 43 Septicaemia Blood Bloody tap Amoxicillin, 
gentamicin 
<1 21 NAD No 
16 1588 30 8 Resp. distress, lethargy, 
bradycardia 
IV No 126 Septicaemia Blood NAD Amoxicillin, 
gentamicin 
<1 21 Hypertonia & 
divergent 
squint 
No  
17 2800 34 6 Resp. distress NIV No 100 Septicaemia Blood NP Amoxicillin, 
gentamicin 
1 21 NR No 
18 2180 34 8 Resp. distress & rash IV Yes 208 Septicaemia, 
meningitis 
Blood NP Amoxicillin, 
cefotaxime 
<1 21 NAD No 
19 1300 29 5 Resp. distress & lethargy IV+HFOV+NO Yes 163 Septicaemia Blood NAD Benzylpenicillin, 
gentamicin 
NR 21 Dev. delay No 
20 2590 35 4 Resp. distress, lethargy, 
bradycardia 
IV+HFOV+NO Yes 137 Septicaemia, 
meningitis 
Blood, 
superficial 
swab 
Bloody tap Cefotaxime 1 21 Dev. delay No 
21 1835 33 3 Seizure & lethargy IV+NO Yes 301 Septicaemia, 
pneumonia 
Blood NAD Amoxicillin, 
gentamicin 
NR 21 Cerebral palsy No 
 
Resp. distress, respiratory distress; IV, invasive ventilation; NIV, non-invasive ventilation; HFOV, high-frequency oscillatory ventilation; NO, nitric oxide; NR, not recorded; CRP, C-reactive protein; CSF, cerebrospinal fluid; NI, not isolated; LP, lumbar puncture; NP, not performed; NAD, no 
abnormality detected; *WCC, white cell count per mm
3
;  #, cases 10 and 12 are probable cases of neonatal listeriosis; NA, not applicable; Dev., developmental;
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Highlights 
 
• Despite its rarity and the prompt and appropriate use of antibiotics neonatal 
listeriosis has a high case-fatality rate  
 
• There is room for improvement in the adherence to the national guidance in the 
choice of empiric antibiotics for puerperal sepsis, which also targets listeriosis 
 
• A better understanding of dietary characteristics based on maternal ethnicities may 
point towards those at higher risk to implement strategies into preventing 
pregnancy-associated listeriosis suggested by the disproportionally high 
representation of Asian and Afro-Caribbean women with listeriosis 
 
 
 
